Clinical Trial Update: Gentian Violet Treatment for Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Gentian Violet for hidradenitis suppurativa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Gentian Violet (gentian violet)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: WITHDRAWN